Targeting CDK2 Protein May Boost Cancer Immunotherapy Effectiveness

A new study indicates that targeting the cell division protein CDK2 could potentially enhance the efficacy of immunotherapy across a wide range of cancers. This scientific discovery opens new avenues for developing treatments aimed at improving the body's immune response against tumors. It offers a promising direction for future cancer therapies.